RU2435844C2 - ШТАММ БАКТЕРИЙ Lactobacillus reuteri ДЛЯ ПОЛУЧЕНИЯ ПРОБИОТИЧЕСКОГО ПРОДУКТА И ПРОБИОТИЧЕСКИЙ ПРОДУКТ, ЕГО СОДЕРЖАЩИЙ - Google Patents

ШТАММ БАКТЕРИЙ Lactobacillus reuteri ДЛЯ ПОЛУЧЕНИЯ ПРОБИОТИЧЕСКОГО ПРОДУКТА И ПРОБИОТИЧЕСКИЙ ПРОДУКТ, ЕГО СОДЕРЖАЩИЙ Download PDF

Info

Publication number
RU2435844C2
RU2435844C2 RU2008147883/10A RU2008147883A RU2435844C2 RU 2435844 C2 RU2435844 C2 RU 2435844C2 RU 2008147883/10 A RU2008147883/10 A RU 2008147883/10A RU 2008147883 A RU2008147883 A RU 2008147883A RU 2435844 C2 RU2435844 C2 RU 2435844C2
Authority
RU
Russia
Prior art keywords
colic
cells
strains
probiotic product
reuteri
Prior art date
Application number
RU2008147883/10A
Other languages
English (en)
Russian (ru)
Other versions
RU2008147883A (ru
Inventor
Эамонн КОННОЛЛИ (SE)
Эамонн КОННОЛЛИ
Бо МЕЛЛЬСТАМ (SE)
Бо МЕЛЛЬСТАМ
Original Assignee
Биогайа Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38790468&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2435844(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Биогайа Аб filed Critical Биогайа Аб
Publication of RU2008147883A publication Critical patent/RU2008147883A/ru
Application granted granted Critical
Publication of RU2435844C2 publication Critical patent/RU2435844C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/853—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
RU2008147883/10A 2006-06-05 2007-05-30 ШТАММ БАКТЕРИЙ Lactobacillus reuteri ДЛЯ ПОЛУЧЕНИЯ ПРОБИОТИЧЕСКОГО ПРОДУКТА И ПРОБИОТИЧЕСКИЙ ПРОДУКТ, ЕГО СОДЕРЖАЩИЙ RU2435844C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/446,628 US7374924B2 (en) 2006-06-05 2006-06-05 Use of selected lactic acid bacteria for reducing infantile colic
US11/446,628 2006-06-05

Publications (2)

Publication Number Publication Date
RU2008147883A RU2008147883A (ru) 2010-07-20
RU2435844C2 true RU2435844C2 (ru) 2011-12-10

Family

ID=38790468

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2008147883/10A RU2435844C2 (ru) 2006-06-05 2007-05-30 ШТАММ БАКТЕРИЙ Lactobacillus reuteri ДЛЯ ПОЛУЧЕНИЯ ПРОБИОТИЧЕСКОГО ПРОДУКТА И ПРОБИОТИЧЕСКИЙ ПРОДУКТ, ЕГО СОДЕРЖАЩИЙ

Country Status (20)

Country Link
US (3) US7374924B2 (cg-RX-API-DMAC7.html)
EP (1) EP2040722B1 (cg-RX-API-DMAC7.html)
JP (3) JP4520531B2 (cg-RX-API-DMAC7.html)
KR (2) KR101030661B1 (cg-RX-API-DMAC7.html)
CN (2) CN102488717B (cg-RX-API-DMAC7.html)
AU (2) AU2007200434B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0710944B8 (cg-RX-API-DMAC7.html)
CA (1) CA2650546C (cg-RX-API-DMAC7.html)
DK (1) DK2040722T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20125480B (cg-RX-API-DMAC7.html)
HU (1) HUE026416T2 (cg-RX-API-DMAC7.html)
IL (1) IL194779A0 (cg-RX-API-DMAC7.html)
MX (1) MX2008014869A (cg-RX-API-DMAC7.html)
MY (1) MY162708A (cg-RX-API-DMAC7.html)
NZ (2) NZ596788A (cg-RX-API-DMAC7.html)
RU (1) RU2435844C2 (cg-RX-API-DMAC7.html)
SI (1) SI2040722T1 (cg-RX-API-DMAC7.html)
UA (1) UA93911C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007142596A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200809531B (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911424B2 (en) 2018-07-24 2024-02-27 Biogaia Ab Selection and use of melatonin supporting bacteria to reduce infantile colic
RU2815940C2 (ru) * 2018-07-24 2024-03-25 Биогайа Аб Выбор и применение обеспечивающих мелатонин бактерий для снижения младенческих колик
WO2025206977A1 (ru) * 2024-03-29 2025-10-02 Александр Владимирович Синица Штамм бактерий lactobacillus reuteri, подавляющий активность helicobacter pylori

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
EP2265135B1 (en) * 2008-03-14 2017-12-20 Nestec S.A. Synbiotic mixture
US9034314B2 (en) * 2008-11-03 2015-05-19 Nestec S.A. Nutritional composition comprising probiotics and improving sleep patterns
AU2014221272B2 (en) * 2008-11-03 2016-01-21 Société des Produits Nestlé S.A. A nutritional composition comprising probiotics and improving sleep patterns
US20110104327A1 (en) * 2009-04-23 2011-05-05 Bacterfield International S.A. Probiotic pet food
EP2459202A1 (en) 2009-07-31 2012-06-06 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
NL2004101C2 (en) * 2010-01-15 2011-07-18 Friesland Brands Bv Ruminant il-10 and use in modulating immune response.
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
KR101706100B1 (ko) * 2011-12-15 2017-02-15 삼성전자주식회사 성형한계선도 획득용 시험장치
EP2609813A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of the enteric nervous system
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
BR112016002650A2 (pt) * 2013-08-09 2017-09-12 Ab Biotics Sa probiótico para choro excessivo infantil
ES2874479T3 (es) * 2014-01-23 2021-11-05 Biogaia Ab Agentes que modulan el dolor gastrointestinal
US11369646B2 (en) * 2014-10-29 2022-06-28 Biogaia Ab Use of L. reuteri for recovery of microbiota dysbiosis in early life
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
JP6529835B2 (ja) * 2015-06-23 2019-06-12 株式会社フィス 樹状細胞活性化剤
CN105219683B (zh) * 2015-11-04 2018-03-13 广东省农业科学院动物科学研究所 一株具有益生特征的罗伊氏乳杆菌菌株及其应用
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
CN106497840B (zh) * 2016-11-07 2019-06-21 江南大学 一种定向分离免疫调节性肠道乳杆菌的方法
EP3827102A1 (en) * 2018-07-24 2021-06-02 Biogaia AB Therapeutic methods using bacterial strains which are capable of increasing adenosine levels
EP3773648B1 (en) * 2019-04-17 2024-06-19 Biogaia AB Therapeutic microvesicles of probiotic bacteria
US20240165171A1 (en) * 2021-03-26 2024-05-23 Seoul National University R&Db Foundation Composition for enhancing physiological efficacy of lactic acid bacteria
CN117925484B (zh) * 2024-03-19 2024-07-09 山东中科嘉亿生物工程有限公司 一株改善睡眠呼吸暂停的罗伊氏粘液乳杆菌jylb-101及其产品和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518696A (en) * 1983-01-11 1985-05-21 Chr. Hansen's Laboratory, Inc. Stabilized liquid bacterial suspension for oral administration to animals
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
US5534253A (en) * 1995-06-07 1996-07-09 Biogaia Ab Method of treating enteropathogenic bacterial infections in poultry
DE69627994D1 (de) * 1995-12-21 2003-06-12 Biogaia Ab Stockholm Verwendung von lactobacillus reuteri zur hemmung der kryptosporidiosis in säugetieren
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
US5800813A (en) * 1996-11-12 1998-09-01 Biogaia Biologics Ab Treatment of cryptosporidium infections
KR19990024297A (ko) * 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1034788A1 (en) 1999-03-11 2000-09-13 Société des Produits Nestlé S.A. Lactic acid bacteria strains capable of preventing diarrhea
EP1344458A1 (en) * 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
US7105336B2 (en) 2002-10-07 2006-09-12 Biogaia Ab Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter
ES2329020T3 (es) * 2002-10-18 2009-11-20 Biogaia Ab Procedimiento para potenciar la funcion inmunitaria en mamiferos usando cepas de lactobacillus reuteri.
US20040208863A1 (en) * 2003-01-30 2004-10-21 James Versalovic Anti-inflammatory activity from lactic acid bacteria
US20040185032A1 (en) 2003-03-18 2004-09-23 David Burrell Compositions and methods for treating colic
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
US7955834B2 (en) * 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
US8603460B2 (en) * 2006-06-05 2013-12-10 Brogaia AB Method of making a Lactobacillus reuteri with increased acid tolerance

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEIZMAN Z, ASLI G, ALSHEIKH A. Effect of a probiotic infant on child care centers: comparison of two probiotic agents. Pediatrics, 2005, v.115(1), p.5-9. VALEUR NANA ET AL. Colonization and immunomodulation by Lactobacillus reuteri ATTC 55730 in the Human Gastrointestinal Tract. Applied and Environmental Microbiology, February 2004, v.70, no.2, p.1176-1181. ШЕНДЕРОВ Б.А. Медицинская микробная экология и функциональное питание. Пробиотики и функциональное питание, т.111. - М.: Грантъ, 2001, с.81-86. *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11911424B2 (en) 2018-07-24 2024-02-27 Biogaia Ab Selection and use of melatonin supporting bacteria to reduce infantile colic
RU2815940C2 (ru) * 2018-07-24 2024-03-25 Биогайа Аб Выбор и применение обеспечивающих мелатонин бактерий для снижения младенческих колик
US12642830B2 (en) 2018-07-24 2026-06-02 Biogaia Ab Selection and use of melatonin supporting bacteria to reduce infantile colic
RU2837786C1 (ru) * 2024-03-29 2025-04-04 Общество с ограниченной ответственностью "Др. Редди'с Лабораторис" Штамм бактерий lactobacillus reuteri salr01, обладающий подавляющим действием в отношении helicobacter pylori
WO2025206977A1 (ru) * 2024-03-29 2025-10-02 Александр Владимирович Синица Штамм бактерий lactobacillus reuteri, подавляющий активность helicobacter pylori

Also Published As

Publication number Publication date
CN102488717B (zh) 2018-03-27
US20070280913A1 (en) 2007-12-06
BRPI0710944A2 (pt) 2017-04-18
US7374924B2 (en) 2008-05-20
JP2010202654A (ja) 2010-09-16
AU2010202976B2 (en) 2012-12-20
NZ596788A (en) 2013-03-28
CN101374533B (zh) 2012-02-01
US20080131414A1 (en) 2008-06-05
DK2040722T3 (en) 2016-02-01
CA2650546A1 (en) 2007-12-13
EP2040722A4 (en) 2010-06-02
JP4520531B2 (ja) 2010-08-04
CA2650546C (en) 2011-08-02
IL194779A0 (en) 2009-08-03
UA93911C2 (ru) 2011-03-25
ZA200809531B (en) 2010-03-31
CN102488717A (zh) 2012-06-13
AU2010202976A1 (en) 2010-08-05
RU2008147883A (ru) 2010-07-20
BRPI0710944B8 (pt) 2021-05-25
HK1125840A1 (en) 2009-08-21
AU2007200434A1 (en) 2007-12-20
NZ572359A (en) 2011-12-22
AU2007200434B2 (en) 2010-09-02
JP2013173749A (ja) 2013-09-05
MY162708A (en) 2017-07-14
WO2007142596A1 (en) 2007-12-13
US9340840B2 (en) 2016-05-17
KR20090015903A (ko) 2009-02-12
KR101308865B1 (ko) 2013-09-17
JP2009539371A (ja) 2009-11-19
KR101030661B1 (ko) 2011-04-20
US9057112B2 (en) 2015-06-16
BRPI0710944B1 (pt) 2020-12-29
JP5865283B2 (ja) 2016-02-17
GEP20125480B (en) 2012-04-25
US20120121564A1 (en) 2012-05-17
MX2008014869A (es) 2008-12-05
HUE026416T2 (en) 2016-07-28
KR20100080565A (ko) 2010-07-08
SI2040722T1 (sl) 2016-02-29
EP2040722B1 (en) 2015-11-11
CN101374533A (zh) 2009-02-25
EP2040722A1 (en) 2009-04-01

Similar Documents

Publication Publication Date Title
AU2007200434B2 (en) Use of selected lactic acid bacteria for reducing infantile colic
CN100552016C (zh) 用于治疗炎性疾病的双歧杆菌
Griffiths et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice
EP1868596B1 (en) Use of lactobacillus rhamnosus gg in combination with a long chain polyunsaturated fatty acid for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant
US20110177126A1 (en) Bacteria and derived products to reinforce the body defences and to reduce the risk of disease
JP2010150206A (ja) 粘膜免疫賦活作用および免疫バランス調整作用を有する経腸栄養剤
MX2007012530A (es) Uso de lactobacillus rhamnosus gg para el tratamiento, prevencion o reduccion de inflamacion sistemica en un infante que se alimenta con formula.
EP1877071A1 (en) Method of improving immune function in mammals using 3-hpa producing lactobacillus strains in combination with medium chain triglyceride oil
TWI351962B (en) Use of selected lactic acid bacteria for reducing
AU2013201542A1 (en) Use of selected lactic acid bacteria for reducing infantile colic
HK1173944A (en) Use of selected lactic acid bacteria for reducing infantile colic
HK1125840B (en) Use of selected lactic acid bacteria for reducing infantile colic
HK1173944B (en) Use of selected lactic acid bacteria for reducing infantile colic

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Free format text: LICENCE

Effective date: 20150213